文献速递主动脉疾病

复杂腹主动脉及胸腹主动脉瘤开窗分支支架主体IIIb型内漏的治疗与结局

Treatment and outcomes of type IIIb endoleaks affecting the main fenestrated-branched aortic stent graft component among patients treated for complex abdominal and thoracoabdominal aortic aneurysms.
PubMed 文献 · J Vasc Surg · 2025-07-17

本研究回顾性分析了2013至2024年间三个中心前瞻性登记研究中接受开窗分支腔内修复术(FB-EVAR)的717例复杂腹主动脉瘤和胸腹主动脉瘤患者,旨在描述主体支架IIIb型内漏(T3bE)的发生率、管理和结局。中位随访37个月,8例(1.1%)确诊T3bE,3年和5年累积发生率分别为1.1%和2.4%。7例接受再次腔内修复,6例成功解决,1例因动脉瘤破裂死亡;1例保守观察自发愈合。T3bE虽罕见但诊断和治疗具有挑战性,需密切监测和及时干预。

要点

  • FB-EVAR后主体支架T3bE发生率低,3年和5年累积发生率分别为1.1%和2.4%。
  • 多数T3bE可通过再次腔内修复成功解决,但仍有动脉瘤破裂致死的风险。
  • 对FB-EVAR术后患者需警惕T3bE,应坚持影像学监测以及时发现并干预。

核心结论

  • FB-EVAR后由织物撕裂或完整性问题导致的T3bE不常见,但诊断和治疗具有挑战性,尤其是当受累段涉及开窗和分支时。
  • 再次腔内修复对部分患者有效,持续性内漏可能导致瘤囊扩张和破裂,强调需要警惕监测和及时干预。

研究设计与样本

  • 回顾性分析2013至2024年间三个中心前瞻性、非随机、医生发起的IDE研究中的连续患者临床数据、影像和结局。
  • 共纳入717例接受FB-EVAR治疗的复杂腹主动脉瘤和胸腹主动脉瘤患者(69%男性,平均年龄74±8岁)。
  • T3bE诊断通过增强超声、标准或动态CTA和/或诊断性血管造影确认。

主要发现

  • 中位随访37个月(IQR 25-40),8例(1.1%)确诊主体支架T3bE。
  • T3bE 3年和5年累积发生率分别为1.1%(95%CI 0.0%-2.2%)和2.4%(95%CI 0.6%-4.3%)。
  • 8例中7例接受再次腔内修复(3例redo开窗分支装置,平行支架、cuff延伸、弹簧圈各1例),7例二次干预成功解决T3bE。
  • 1例因动脉瘤破裂导致死亡;1例保守观察自发愈合。

临床怎么用

  • FB-EVAR术后应进行规律影像学监测,以便早期发现T3bE。
  • 确诊T3bE后,对于适合的患者可优先考虑再次腔内修复。
  • 对于持续性内漏,需警惕瘤囊扩张和破裂风险,及时干预。

局限性

  • T3bE发生率低,样本量小(8例),结果可能受限。
  • 来自三个中心的前瞻性IDE研究,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Type IIIb endoleak (T3bE) owing to fabric tears or integrity issues is infrequent, but has been poorly described among patients undergoing fenestrated-branched endovascular aortic repair (FB-EVAR). This study aimed to describe the incidence, management, and outcomes of T3bE after FB-EVAR for the treatment of complex abdominal aortic aneurysms (CAAAs) and thoracoabdominal aortic aneurysms (TAAAs). METHODS: Clinical data, imaging, and outcomes of consecutive patients enrolled in prospective, nonrandomized physician-sponsored investigational device exemption studies evaluating company-manufactured devices for FB-EVAR at three centers were reviewed from 2013 to 2024. Patients with unequivocal diagnosis of T3bE affecting the main fenestrated-branched aortic device component, confirmed by contrast-enhanced ultrasound examination, standard or dynamic computed tomography angiography (CTA), and/or diagnostic angiography, were included. The primary end point was the cumulative incidence of T3bE. Secondary end points included treatment approaches, mortality, major adverse events, secondary interventions, and aneurysm rupture. RESULTS: A total of 717 patients (69% male; mean age, 74 ± 8 years old) were treated by FB-EVAR in the two centers. After a median follow-up of 37 months (interquartile range [IQR], 25-40 months), eight patients (1.1%) had unequivocal diagnosis of T3bE affecting the main component of a fenestrated-branched device. Cumulative incidence of T3bE at 3 and 5 years was 1.1% (95% confidence interval, 0.0%-2.2%) and 2.4% (95% confidence interval, 0.6%-4.3%), respectively. All patients had prior imaging showing no T3bE. Surveillance imaging with a final diagnosis of T3bE was established by angiography in three patients, contrast-enhanced ultrasound examination in two, dynamic CTA in two, and CTA in one. Of the eight patients, seven underwent endovascular repair with redo fenestrated-branch device in three, and parallel stent graft, cuff extension, or endovascular plug/coils in one each. Seven secondary interventions successfully resolved the T3bE with one patient presenting with an aneurysm rupture leading to mortality. One patient was managed conservatively with clinical surveillance and had spontaneous resolution of the endoleak. The overall median follow-up was 55 months (IQR, 42-62 months), and the median follow-up after T3bE reintervention was 20 months (IQR, 5-28 months). CONCLUSIONS: T3bEs from fabric tears or integrity issues are uncommon after FB-EVAR, but pose diagnostic and treatment challenges, particularly when the affected segment involves fenestrations and directional branches. Redo endovascular repair is effective in selected patients. Persistent leaks may lead to aneurysm sac expansion and rupture, emphasizing the need for vigilant surveillance and timely intervention.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ruiter Kanamori L, Dias-Neto M, Porras-Colon J, et al. Treatment and outcomes of type IIIb endoleaks affecting the main fenestrated-branched aortic stent graft component among patients treated for complex abdominal and thoracoabdominal aortic aneurysms. J Vasc Surg. 2025. PMID: 40683396. doi:10.1016/j.jvs.2025.06.112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。